High level of vaccination and protection against hepatitis B with low rate of HCV infection markers among hospital health care personnel in north of Iran: a cross-sectional study

BMC Public Health
Saffar HivaMohammed-Jafar Saffar

Abstract

hepatitis B virus (HBV) and C virus (HCV) are among the leading causes of mortality worldwide. Health care personnel (HCP) are subjected to increased risk of these infections. Therefore, HBV vaccination and post-vaccination serologic testing (PVST) are recommended for them. Our objectives in this study were investigate how well the vaccination guidelines for hospital HCPs were implemented. Moreover, the prevalence rates of HBV and HCV infections were calculated. To determine the presence of immunological memory, vaccinated personnel negative to antibody against HB surface antigen with one dose of HB vaccine were boosted. From 1 July to 30 November 2017, a cross-sectional study among HCPs working in public hospitals were conducted. All HCPs from various professional categories potentially at risk of exposure to contaminated sources were included. The information was gathered via interview and self-administered questionnaire. The questions were focused on the demographic characteristics, HB vaccination and immunity status and time elapsed since initial vaccination series, and frequency of needelstick injuries during the past 12 months of their work. Moreover, the prevalence rate of HBV and HCV infections were calculated. To deter...Continue Reading

References

Jul 25, 2000·Clinical Microbiology Reviews·E M BeltramiM E Chamberland
Dec 22, 2004·Journal of Gastroenterology and Hepatology·T Jacob JohnUNKNOWN Steering Committee for the Prevention and Control of Infectious Diseases in Asia
Sep 8, 2010·European Journal of Public Health·Antoon De SchryverGuido François
Jun 18, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·S Deuffic-BurbanY Yazdanpanah
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Khayriyyah Mohd HanafiahSteven T Wiersma
Nov 2, 2013·Public Health Reports·Kathy K ByrdTrudy V Murphy
Mar 22, 2014·Journal of Renal Care·Monique M ElseviersHans-Jürgen Arens
Jul 31, 2014·Revista Do Instituto De Medicina Tropical De São Paulo·Eduardo Pernambuco de Souza, Marcelo de Souza Teixeira
Nov 13, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naveen GaraMarc G Ghany
Aug 5, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert G GishKris V Kowdley
Oct 20, 2015·World Journal of Gastroenterology : WJG·Reza Taherkhani, Fatemeh Farshadpour
Mar 1, 2016·World Journal of Hepatology·Nicola CoppolaEvangelista Sagnelli
Mar 5, 2016·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Mikio YanaseMasashi Mizokami
Jun 4, 2016·Hepatitis Monthly·Mostafa Salehi-VaziriSeyed Moayed Alavian
Dec 28, 2016·Human Vaccines & Immunotherapeutics·A DomínguezUNKNOWN Working Group for the Study of the Immune Status in Healthcare Workers of Catalonia
Feb 18, 2017·International Journal of Environmental Research and Public Health·Maria GanczakGrażyna Adler
Jul 3, 2018·Euroasian Journal of Hepato-gastroenterology·David H MuljonoRizalinda Sjahril
Oct 26, 2018·BioMed Research International·Desmond ArokeLarry Tangie Ngek

❮ Previous
Next ❯

Citations

Aug 8, 2021·International Journal of Environmental Research and Public Health·Andrea TrevisanChiara Bertoncello

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.